Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Atypical cartilage in type II germ cell tumors of the mediastinum show significantly different patterns of IDH1/2 mutations from conventional chondrosarcoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2022

Same author

Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2022

Same author

Evaluating mismatch repair deficiency for solid tumor immunotherapy eligibility: immunohistochemistry versus microsatellite molecular testing.

Human pathology·2021

Same author

Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation.

Oncotarget·2017

Same author

Utilization of Cell-Transfer Technique for Molecular Testing on Hematoxylin-Eosin-Stained Sections: A Viable Option for Small Biopsies That Lack Tumor Tissues in Paraffin Block.

Archives of pathology & laboratory medicine·2016

Same author

Detection of BRAF mutations on direct smears of thyroid fine-needle aspirates through cell transfer technique.

American journal of clinical pathology·2015

Search research articles

Related Experiment Video

Updated: May 2, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Performance evaluation comparison of 3 commercially available PCR-based KRAS mutation testing platforms.

Julia A Adams¹, Kristin M Post, Sarah A Bilbo

¹Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN.

Applied Immunohistochemistry & Molecular Morphology : AIMM

|March 12, 2014

Summary

This study compared three polymerase chain reaction (PCR)-based tests for KRAS mutation detection. Qiagen therascreen RGQ and Qiagen KRAS Pyro demonstrated superior sensitivity and accuracy compared to Applied Biosystems for KRAS mutation testing.

More Related Videos

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines

Published on: October 8, 2015

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Published on: September 25, 2018

Related Experiment Videos

Last Updated: May 2, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines

Published on: October 8, 2015

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Published on: September 25, 2018

Area of Science:

Oncology
Molecular Diagnostics
Genetics

Background:

KRAS mutations are critical biomarkers in colonic adenocarcinoma and non-small cell lung carcinoma.
Identifying KRAS mutations is essential for contraindicating epidermal growth factor receptor-targeted therapies.
Several PCR-based tests exist for KRAS mutation analysis, but direct comparisons are limited.

Purpose of the Study:

To evaluate and compare the performance characteristics and workflow of three commercially available PCR-based KRAS mutation detection platforms.
To provide a side-by-side analysis of different KRAS testing methods.

Main Methods:

Performance evaluation of three PCR-based KRAS mutation detection platforms: Applied Biosystems KRAS Mutation Analysis, Qiagen therascreen KRAS RGQ PCR, and Qiagen KRAS Pyro.
Analysis of 188 patient samples for KRAS mutation status.
Comparison of sensitivity, specificity, positive predictive value, negative predictive value, and accuracy.

Main Results:

All 188 samples were successfully analyzed, with 29% testing positive for KRAS mutations.
Qiagen therascreen RGQ and Qiagen KRAS Pyro detected 100% of positive cases, while Applied Biosystems detected 84%.
Qiagen therascreen RGQ and Pyro showed 100% sensitivity, specificity, and accuracy, outperforming Applied Biosystems.

Conclusions:

Qiagen therascreen RGQ and Qiagen KRAS Pyro are highly comparable and accurate for KRAS mutation detection.
Applied Biosystems KRAS Mutation Analysis exhibits slightly lower sensitivity, negative predictive value, and accuracy.
All three methods accurately identified mutations in control specimens, but Qiagen platforms offer superior performance.